Sign in Subscribe
Cardiology

Diabetic Patients Show Positive Results with Cypher Stent Treatment

Strategic Insights

— 1 min read

Diabetic patients with clogged arteries, particularly those with insulin-dependent and non-insulin-dependent diabetes, can now breathe a sigh of relief with the promising results of a clinical study conducted at the Washington Hospital Center. The study has shown that the Cypher Sirolimus-eluting Coronary Stent can effectively treat clogged arteries in diabetic patients with a low incidence of repeat coronary procedures. The study enrolled 1407 patients, divided into three groups: insulin-dependent diabetics, non-insulin dependent diabetics, and patients without diabetes. The findings indicate that diabetic patients faired as well statistically as those without diabetes, with extremely low rates of adverse events, including the need for retreatment, heart attacks, and death.

Key Takeaways:

  • The study found that diabetic patients treated with the Cypher Stent had a low incidence of repeat coronary procedures, comparable to patients without diabetes.
  • The study enrolled 1407 patients, with 160 insulin-dependent diabetics, 332 non-insulin dependent diabetics, and 915 patients without diabetes.
  • Follow-up evaluations were conducted for all groups, including 6-month post-procedure evaluations.
  • The study found no significant differences in mortality between the groups, with rates ranging from 2.3% to 4.5%.
  • Target lesion revascularization (TLR) rates were also comparable between the groups, ranging from 0.4% to 1.5%.
  • The Cypher Stent has been shown to reduce reblockage in the arteries by more than 90% over a conventional bare metal stent.

Statistics:

  • 1407 patients were enrolled in the study, with 160 insulin-dependent diabetics, 332 non-insulin dependent diabetics, and 915 patients without diabetes.
  • 6-month mortality rates were 2.3% for non-diabetic patients, 3.8% for IDDM patients, and 4.5% for non-IDDM patients.
  • Target lesion revascularization (TLR) rates were 0.4% for IDDM patients, 0.9% for non-IDDM patients, and 1.5% for non-diabetic patients.
  • Overall MACE rates were 6.2% for non-diabetic patients, 7.9% for IDDM patients, and 8.0% for non-IDDM patients.

Sources:

  • "Positive results for diabetic patients with Cypher Stent," NewsRx.com & NewsRx.net, December 19, 2004
  • Heart Disease Weekly, via NewsRx.com & NewsRx.net.

Read more